Document Detail

Differential microRNA Profile and Post-Transcriptional Regulation Exist in Systemic Lupus Erythematosus Patients with Distinct Autoantibody Specificities.
MedLine Citation:
PMID:  24659206     Owner:  NLM     Status:  Publisher    
PURPOSE: Systemic lupus erythematosus (SLE) patients have anti-nuclear autoantibodies directed against dsDNA and RNA-associated antigens (extractable nuclear antigens; ENA). In this study, we investigated the differences in microRNA (miRNA) expression and its biological implications in SLE patients with distinct autoantibody specificities.
METHODS: The SLE patients were grouped into three subsets based on the type of autoantibodies present in their sera (anti-ENA(+) group with autoantibodies against ENA alone; anti-dsDNA(+) group having autoantibodies against dsDNA only, and anti-ENA(+)dsDNA(+) group having autoantibodies to both dsDNA and ENA). Global miRNA expression profiling was done for each of these three groups using TaqMan® low density miRNA arrays.
RESULTS: We report that different sets of miRNAs are dysregulated in SLE patients with different autoantibody specificities. Further, Ingenuity pathway analysis (IPA) software revealed specific biological pathways that were targeted by miRNAs dysregulated in different SLE subsets. Molecules involved in cell cycle and cytoskeleton remodeling were the prime targets of miRNAs dysregulated in anti-ENA(+) patients whereas miRNAs dysregulated in anti-dsDNA(+) patients were found to be implicated in multiple cytokine signaling pathways. IPA analysis of gene targets of miRNAs commonly dysregulated in all three SLE subsets identified several metabolic-, hormone-, and interferon-related pathways to be affected.
CONCLUSION: The differential miRNA expression in patients with distinct autoantibodies is suggestive of different regulatory mechanisms operating among them. Based on these observations, we are hopeful that this 'sub-grouping' approach could be used to identify other defective processes associated with varying disease manifestations in SLE and may be considered when designing therapeutic interventions.
Sudhir Kumar Chauhan; Vikas Vikram Singh; Richa Rai; Madhukar Rai; Geeta Rai
Related Documents :
23320006 - Central nervous system (cns) involvement is a critical prognostic factor for hemophagoc...
23279026 - Acetaminophen administration in a patient with gilbert's syndrome.
24316666 - What is the future of acute respiratory distress syndrome after the berlin definition?
24191396 - Clinical significance of autoantibodies to parietal cells in patients with autoimmune t...
19422986 - Tachycardia-mediated cardiomyopathy secondary to focal atrial tachycardia: long-term ou...
21286446 - Transient cauda equina syndrome related to a sacral schwannoma with cauda equine compre...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-3-23
Journal Detail:
Title:  Journal of clinical immunology     Volume:  -     ISSN:  1573-2592     ISO Abbreviation:  J. Clin. Immunol.     Publication Date:  2014 Mar 
Date Detail:
Created Date:  2014-3-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8102137     Medline TA:  J Clin Immunol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Does immobilization position after arthroscopic rotator cuff repair impact work quality or comfort?
Next Document:  Can soy intake affect serum uric acid level? Pooled analysis from two 6-month randomized controlled ...